Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(13 sites)
United States
University of California Irvine, Orange, California Mayo Clinic, Jacksonville, Florida University of Miami, Miami, Florida Sarasota Memorial Hospital, Sarasota, Florida University of Iowa, Iowa City, Iowa